Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




High Asymmetric Dimethylarginine Linked to Diabetic Retinopathy
Link ID 1857
Title High Asymmetric Dimethylarginine Linked to Diabetic Retinopathy
Url http://www.medscape.com/viewarticle/567768?src=rss
Description Elevated levels of circulating asymmetric dimethylarginine (ADMA) appear to be associated with diabetic retinopathy, particularly in patients with type 2 diabetes, according to a report in the November issue of Diabetes Care. Reuters Health Information
Category Articles > Diabetes and Endocrinology
Keywords
Date Dec 25, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Diabetes and Endocrinology
1. Diabetic Drug Taken Once Weekly Provides Sustained Glucose Control
  Patients with type 2 diabetes achieve better glycemic control with once-weekly exenatide than with the twice-daily formulation. Medscape Medical News
Category:   Articles > Diabetes and Endocrinology


2. Study Finds Bidirectional Link Between Depression and Type 2 Diabetes
  A new study shows that patients with diabetes have an increased risk of developing depression, and those with depression have an increased risk of developing diabetes. Medscape Medical News
Category:   Articles > Diabetes and Endocrinology


3. Mild Cognitive Impairment Linked to Diabetes Duration, Severity
  A new study suggests an association between mild cognitive impairment with an earlier onset, longer duration, and greater severity of diabetes mellitus. Medscape Medical News
Category:   Articles > Diabetes and Endocrinology


4. Moderate Fitness Reduces Mortality Risk for Men With Type 2 Diabetes
  The risk for death is 40% to 50% lower for moderately and highly fit individuals, regardless of weight. Medscape Medical News
Category:   Articles > Diabetes and Endocrinology


5. Paclitaxel-Eluting Coronary Stents Safe, Effective in Diabetic Patients
  In patients with diabetes, treatment of noncomplex coronary lesions with paclitaxel-eluting stents is safe and effective, and results in lower rates of target lesion revascularization compared with treatment with bare-metal stents, according to an analysis reported in the February 19th issue of the Journal of the American College of Cardiology Reuters Health Information
Category:   Articles > Diabetes and Endocrinology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS